Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Recurrent Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Gabrielle Deveber, MD MSc, Fenella Jane Kirkham, MD, Kelsey Shannon, Leonardo R. Brandao, MD MSc, Ronald Sträter, Gili Kenet, MD, Hartmut Clausnizer, Mahendranath Moharir, Martina Kausch, Rand Askalan, Daune MacGregor, Monika Stoll, Antje Torge, Nomazulu Dlamini, Vijeya Ganesan, Mara Prengler, Jaspal Singh, Ulrike Nowak Goettl

Blood (2018) 132 (Supplement 1): 3808.

https://doi.org/10.1182/blood-2018-99-118914

Published: 2018

Journal Articles

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Blood (2018) 132 (Supplement 1): 2472.

https://doi.org/10.1182/blood-2018-99-114518

Published: 2018

Journal Articles

Activated Protein C Induces Stabilization of the Outer Retinal Barrier and Inhibits Laser Induced Choroidal Neovascularization in a Murine Model

Tami Livnat, PhD, Yael Nisgav, Msc, Ivan Budnik, MDPhD, Yehonatan Weinberger, MD, Rima Dardik, PhD, Gili Kenet, MD, Dov Weinberger, MD

Blood (2018) 132 (Supplement 1): 73.

https://doi.org/10.1182/blood-2018-99-111375

Published: 2018

Journal Articles

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Gili Kenet, MD, Andres Brainsky, MD, Jerry S. Powell, MD, Yanyan Li, PhD, Wilfried Seifert, PhD

Blood (2017) 130 (Supplement 1): 2370.

https://doi.org/10.1182/blood.V130.Suppl_1.2370.2370

Published: 2017

Journal Articles

Reclassification of Pre-Diagnosed Von-Willebrand Disease in the Eldery: A Hospital-Based Cohort Study

Ulrike Nowak Goettl, Dorothee Caliebe, Dorothee Kowalski, Shneyder Maria, Verena Elsa Limperger, MD, Gili Kenet, MD

Blood (2017) 130 (Supplement 1): 3685.

https://doi.org/10.1182/blood.V130.Suppl_1.3685.3685

Published: 2017

Journal Articles

Estimating the Cost Savings and Cost Effectiveness of Low Dose Immune Tolerance Induction (ITI) Therapy with Bypassing Agent Prophylaxis Compared to High Dose ITI and Low Dose ITI

Gili Kenet, MD, Abiola Oladapo, PhD BPharm, Josh Epstein, PhD, Thompson Christin, PhD, Aaron Novack, Diane J. Nugent, MD

Blood (2017) 130 (Supplement 1): 4632.

https://doi.org/10.1182/blood.V130.Suppl_1.4632.4632

Published: 2017

Journal Articles

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Blood (2016) 128 (22): 3774.

https://doi.org/10.1182/blood.V128.22.3774.3774

Published: 2016

Journal Articles

Comparison of Rethrombosis-Free Survival in Children Versus Adults Suffering from Antithrombin-, Protein C- and Protein S-Deficiency: An Observational Multicenter Cohort Study

Verena Limperger, MD, Gili Kenet, MD, Christine Heller, MD, Ralf Knoefler, MD, Karin Kurnik, MD, Ulrich C Klostermeier, MD, Rolf Mesters, MD, Neil A Goldenberg, MD PhD, Guy Young, MD, Ulrike Nowak-Gottl, MD

Blood (2015) 126 (23): 2316.

https://doi.org/10.1182/blood.V126.23.2316.2316

Published: 2015

Journal Articles

Influence of Gender and Coagulation Factors on Efficacy and Safety of Rivaroxaban in Adolescents & Young Adults with Venous Thromboembolism

Manuela Krause, MD, Verena Limperger, MD, Anna Henningsen, Hartmut Clausnizer, Gili Kenet, MD, Dorothee Kowalski, Ulrike Nowak-Gottl, MD

Blood (2015) 126 (23): 4729.

https://doi.org/10.1182/blood.V126.23.4729.4729

Published: 2015

Journal Articles

Beyond the Bethesda Assay- Towards Individualized Interpretation of Inhibitor Patients' FVIII Brand Specific Profiles

Tami Livnat, PhD, Amy Dunn, Shirley Azar- Avivi, Courtney Cox, Einat Avishai, Shannon L. Meeks, MD, Gili Kenet, MD

Blood (2014) 124 (21): 2841.

https://doi.org/10.1182/blood.V124.21.2841.2841

Published: 2014

Journal Articles

Impact of SERPINC1, PROC and PROS1 Mutations on the Thrombotic Phenotype in Children with Venous Thromboembolism: An Observational Multicenter Cohort Study

Verena Limperger, Gili Kenet, MD, Christine Heller, MD, Karin Kurnik, Ralf Knoefler, Rolf M Mesters, MD, Susan Halimeh, MD, Ulrike Nowak-Göttl

Blood (2014) 124 (21): 583.

https://doi.org/10.1182/blood.V124.21.583.583

Published: 2014

Journal Articles

A Simple Two Step Approach for Diagnosis of Heparin Induced Thrmbocytopenia Using 4T Score and PaGIA Testing

Aaron Lubetsky, MD, Gili Kenet, MD, Nurit Rosenberg, PhD, Ilia Tamarin

Blood (2014) 124 (21): 1449.

https://doi.org/10.1182/blood.V124.21.1449.1449

Published: 2014

Journal Articles

Efficacy and Safety of Rivaroxaban: An Observationalmulticenter Cohort Study Reporting the Routine Use in Adolescents & Adults with DVT

Manuela Krause, MD, Alexander Bauer, Hartmut Clausnizer, Gili Kenet, MD, Dorothee Kowalski, Verena Limperger, Ann-Kathrin Pilgrimm-Thorp, Daniela Manner, MD, Ulrike Nowak-Göttl, Prof.

Blood (2014) 124 (21): 5083.

https://doi.org/10.1182/blood.V124.21.5083.5083

Published: 2014

Journal Articles

Influence Of Antithrombin Deficiency On Symptomatic Recurrent Venous Thromboembolism (VTE) In Children: A Multicenter Cohort Study

Gili Kenet, MD, Verena Limperger, Neil A Goldenberg, MD, PhD, Christine Heller, Susanne Holzhauer, MD, Shoshana Revel- Vilk, Guy Young, MD, Ulrike Nowak- Gottl

Blood (2013) 122 (21): 3619.

https://doi.org/10.1182/blood.V122.21.3619.3619

Published: 2013

Journal Articles

Epitope Specific Discrepancies Between Antibody Mediated Inhibition Of Recombinant Factor VIII and Plasma Derived Factor VIII Containing Von Willebrand Factor Affecting All Domains Of Factor VIII

Tami Livnat, PhD, Amy L. Dunn, MD, Shirley Azar-Avivi, Wallace Hunter Baldwin, B.S., Gili Kenet, MD, Shannon L. Meeks, MD

Blood (2013) 122 (21): 1089.

https://doi.org/10.1182/blood.V122.21.1089.1089

Published: 2013

Journal Articles

Influence of Factor V G1691A or Prothrombin G20210A Mutation On Inhibitor Development in Patients with Severe Hemophilia A - an Israeli-German Database Study.

Gili Kenet, MD, Christoph Bidlingmaier, Carmen Escuriola Ettingshausen, MD, Sven Gutsche, MD, Susan Halimeh, MD, Verena Janssen, MD, Karin Kurnik, MD, Ulrike Nowak-Gottl, MD

Blood (2012) 120 (21): 2234.

https://doi.org/10.1182/blood.V120.21.2234.2234

Published: 2012

Journal Articles

Trace FVIII Augments Rfviia Induced Thrombin Generation and Improves Hemostasis in Hemophilia A Patients with Inhibitors: A clinical Cohort Study

Tami Livnat, PhD, Uri Martinowitz, MD, Shirley Azar-Avivi, Ariela Zivelin, PhD, Gili Kenet, MD

Blood (2012) 120 (21): 40.

https://doi.org/10.1182/blood.V120.21.40.40

Published: 2012

Journal Articles

A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study

Susanne Holzhauer, MD, Christoph Bidlingmaier, MD, Carmen Escuriola Ettingshausen, MD, Susan Halimeh, MD, Alfonso Iorio, MD, Gili Kenet, MD, Brigitte Pautard, MD, Ulrike Nowak-Gottl, MD

Blood (2010) 116 (21): 710.

https://doi.org/10.1182/blood.V116.21.710.710

Published: 2010

Journal Articles

Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]

Gili Kenet, MD, Mariana Bonduel, Anthony Chan, MBBS, FRCPC, FRCPath, Neil Goldenberg, Suzzane Holtzhauer, Alfonso Iorio, Janna M. Journeycake, MD, Ralf Junker, Christoph Male, Mary Patricia Massicotte, MD, Rolf M. Mesters, Paul Monagle, MBBS, MD, MSc, Heleen Van Ommen, Leslie Raffini, MD, Paolo Simioni, Guy Young, MD, Ulrike Nowak-Gottl, MD

Blood (2010) 116 (21): 3169.

https://doi.org/10.1182/blood.V116.21.3169.3169

Published: 2010

Journal Articles

Post-Thrombotic Syndrome (PTS) in Children: A Systematic Review of Prevalence, Validity of Outcome Measures, and Prognostic Factors.

Neil A Goldenberg, MD, PhD, Susan Kahn, MD, MSc, Mark A. Crowther, MD, Gili Kenet, MD, PhD, Ulrike Nowak-Gottl, MD, Marilyn J. Manco-Johnson

Blood (2009) 114 (22): 2978.

https://doi.org/10.1182/blood.V114.22.2978.2978

Published: 2009

NARROW

Recurrent Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Activated Protein C Induces Stabilization of the Outer Retinal Barrier and Inhibits Laser Induced Choroidal Neovascularization in a Murine Model

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Reclassification of Pre-Diagnosed Von-Willebrand Disease in the Eldery: A Hospital-Based Cohort Study

Estimating the Cost Savings and Cost Effectiveness of Low Dose Immune Tolerance Induction (ITI) Therapy with Bypassing Agent Prophylaxis Compared to High Dose ITI and Low Dose ITI

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Comparison of Rethrombosis-Free Survival in Children Versus Adults Suffering from Antithrombin-, Protein C- and Protein S-Deficiency: An Observational Multicenter Cohort Study

Influence of Gender and Coagulation Factors on Efficacy and Safety of Rivaroxaban in Adolescents & Young Adults with Venous Thromboembolism

Beyond the Bethesda Assay- Towards Individualized Interpretation of Inhibitor Patients' FVIII Brand Specific Profiles

Impact of SERPINC1, PROC and PROS1 Mutations on the Thrombotic Phenotype in Children with Venous Thromboembolism: An Observational Multicenter Cohort Study

A Simple Two Step Approach for Diagnosis of Heparin Induced Thrmbocytopenia Using 4T Score and PaGIA Testing

Efficacy and Safety of Rivaroxaban: An Observationalmulticenter Cohort Study Reporting the Routine Use in Adolescents & Adults with DVT

Influence Of Antithrombin Deficiency On Symptomatic Recurrent Venous Thromboembolism (VTE) In Children: A Multicenter Cohort Study

Epitope Specific Discrepancies Between Antibody Mediated Inhibition Of Recombinant Factor VIII and Plasma Derived Factor VIII Containing Von Willebrand Factor Affecting All Domains Of Factor VIII

Influence of Factor V G1691A or Prothrombin G20210A Mutation On Inhibitor Development in Patients with Severe Hemophilia A - an Israeli-German Database Study.

Trace FVIII Augments Rfviia Induced Thrombin Generation and Improves Hemostasis in Hemophilia A Patients with Inhibitors: A clinical Cohort Study

A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study

Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]

Post-Thrombotic Syndrome (PTS) in Children: A Systematic Review of Prevalence, Validity of Outcome Measures, and Prognostic Factors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only